NCT01595074View on ClinicalTrials.gov

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Not yet recruitingOBSERVATIONAL
Enrollment

950

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2100

Conditions
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung Cancer
Interventions
OTHER

medical chart review

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

K7L 3N6

National Cancer Institute of Canada Clinical Trials Group, Kingston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH